Featured

The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement

Yuvraj — Mon, 06 Apr 2026 08:17:20 +0000

Why Field Execution Must Evolve Field execution — how pharma companies organize, direct, and deliver commercial and medical interactions with healthcare professionals (HCPs), prescribers, and institutional decision-makers (collectively, “customers”) — is a major contributor to commercial success. Accordingly, over the past decade, companies have invested heavily in sales force effectiveness, key account management, omnichannel strategies, […]

The post The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement first appeared on World Pharma Today.

FDA Looks to Accelerate Biosimilar Drug Development

Yuvraj — Tue, 25 Nov 2025 13:33:37 +0000

The FDA has gone on to propose certain new policies in order to accelerate biosimilar drug development and at the same time also lower the cost pertaining to biosimilar agents when it comes to cancer as well as any other serious illnesses. These policies go on to include major updates so as to simplify the biosimilarity […]

The post FDA Looks to Accelerate Biosimilar Drug Development first appeared on World Pharma Today.

Automated Fluid Transfer in Biomanufacturing Systems

Yuvraj — Tue, 20 May 2025 07:28:57 +0000

Automation in Fluid Transfer: From Manual to Modular Systems in Biomanufacturing A fundamental component of biomanufacturing, fluid transfer links upstream and downstream processes and enables the flow of precious biomaterials. Historically, fluid transfer depended mostly on human operations—tubing changes, valve manipulations, and pump adjustments—often including labour-intensive and error-prone processes. Automation is changing these fluid transfer […]

The post Automated Fluid Transfer in Biomanufacturing Systems first appeared on World Pharma Today.

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Yuvraj — Wed, 26 Mar 2025 06:48:31 +0000

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong Pharma Support European life sciences investment firm Sofinnova Partners has announced the final close of its second biotech acceleration fund, raising €165 million and surpassing its original target. The fund, Sofinnova Biovelocita II, now holds the title as the largest pan-European initiative of its kind, with […]

The post Pharma Support Powers Sofinnova Biotech Acceleration Fund first appeared on World Pharma Today.

Regenerative Medicine Makeover Via Artificial Intelligence

Yuvraj — Sat, 15 Mar 2025 07:50:43 +0000

While the regenerative medicine spectrum continues its upward trend, artificial intelligence incorporation happens to be playing a role that’s especially transformative in the pharmaceutical sector. The fact is that AI-driven drug discovery can go on to evaluate chemical compounds that are in the millions in a fraction of the time it would usually take by […]

The post Regenerative Medicine Makeover Via Artificial Intelligence first appeared on World Pharma Today.

Artificial Intelligence – Giving Clinical Trial A Facelift

Yuvraj — Sat, 15 Mar 2025 07:40:40 +0000

Across the past so many years, there have been pharmaceutical companies that have been integrating artificial intelligence steadily into many elements of clinical development. The effect that artificial intelligence has today is indeed being felt right from the bench to the clinic and even beyond. As per the survey conducted by the Tufts Centre for […]

The post Artificial Intelligence – Giving Clinical Trial A Facelift first appeared on World Pharma Today.

Pharmaceutical Contract Sales Market to Hit $26.24B by 2034

Yuvraj — Tue, 11 Mar 2025 06:51:04 +0000

Contract Sales Organizations: Transforming Pharma Companies Contract sales organizations – CSOs are becoming vital tools for pharmaceutical companies to boost sales performance while keeping marketing costs low. These organizations happen to offer experts who work alongside pharmaceutical companies in order to distribute and promote their products. Contract sales organizations apply their extensive industry knowledge and […]

The post Pharmaceutical Contract Sales Market to Hit $26.24B by 2034 first appeared on World Pharma Today.

Indian Pharma Grows 8% CAGR, Surpassing Global Average

Yuvraj — Sat, 08 Mar 2025 08:01:54 +0000

The Indian pharma sector has seen 8% CAGR growth and at the same time has witnessed a 9% rise when it comes to export rates in 2024, as per one of the reports. McKinsey & Company’s report has shown that the pharma sector in India happens to be witnessing very fast growth as far as […]

The post Indian Pharma Grows 8% CAGR, Surpassing Global Average first appeared on World Pharma Today.